1.79
-3.24%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Acenta Group
Its shares trade on Nasdaq Stockholm under the ticker PADEL.ST. It has been listed since 2 October 2014. In the fiscal year to 31 December 2025, it reported revenue of SEK 20.2m and a net loss of SEK 28.9m. At that date it held total assets of SEK 18.5m and shareholders' equity of −SEK 3.8m.
Bonzun AB engages in the development and production of research based digital programs that aids consumer to lower the risk of mental illness. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2014-10-02. Its offering application, which helps users to has a better control over their life, health and wellbeing. The Companys main products are: Bonzun IVF is a personalized and complete IVF app, its smart tools and emotional support to increase chances to succeed with ART treatments IVF, ICSI or Frozen Embryo Transfer (FET); Bonzun evolve helps companies and their employees to develop and strengthen their self-leadership and coping mechanisms to deal with stressful situations in the work environment and Kou Dai Yun Yu app, the virtual midwife, helps pregnant women understand when it is time to seek a doctor and when it is safe to stay home.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Communication Services
- Industry
- Interactive Media & Services
- Listed since
- 2 Oct 2014
- Website
- bonzun.com ↗
Leadership
Pay as last reported
- Mr. Hakan JohanssonChairman of the Board, Acting Chief Executive Officer, since 2020
- Ms. Kerstin LayeChief Financial Officer
- Mr. Anders TengstromResearch Manager, Director
- Ms. Veronica PetterssonDirector of Sales
- Mr. Jacob DahlborgDirector
- Ms. Madeleine DahlstromDirector
- Ms. Asa IndeDirector
- Ms. Kajsa RaftegardDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bonzun IVF provides personalized tools to increase success rates for ART treatments.
- The Kou Dai Yun Yu app acts as a virtual midwife for pregnant women.
- Bonzun evolve helps employees develop self-leadership to cope with work stress.
Weaknesses
- The company is headquartered in Stockholm, which may limit local market reach.
- The IPO occurred on 2 October 2014, indicating a mature but established timeline.
- The offering application focuses on life control rather than direct medical diagnosis.
Opportunities
- The digital programs aid consumers in lowering the risk of mental illness.
- Smart tools support users in managing their health and overall wellbeing effectively.
- Emotional support features can strengthen user engagement with the Bonzun platform.
Threats
- Competition in the digital health sector may reduce user adoption rates.
- Regulatory changes in healthcare could impact the development of medical apps.
- User privacy concerns might affect trust in personal health data handling.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.